Arcadia Cash Flows Other Operating vs Begin Period Cash Flow Analysis

RKDA Stock  USD 6.30  0.21  3.45%   
Arcadia Biosciences financial indicator trend analysis is way more than just evaluating Arcadia Biosciences prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Arcadia Biosciences is a good investment. Please check the relationship between Arcadia Biosciences Cash Flows Other Operating and its Begin Period Cash Flow accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Arcadia Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
For information on how to trade Arcadia Stock refer to our How to Trade Arcadia Stock guide.

Cash Flows Other Operating vs Begin Period Cash Flow

Cash Flows Other Operating vs Begin Period Cash Flow Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Arcadia Biosciences Cash Flows Other Operating account and Begin Period Cash Flow. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Arcadia Biosciences' Cash Flows Other Operating and Begin Period Cash Flow is -0.44. Overlapping area represents the amount of variation of Cash Flows Other Operating that can explain the historical movement of Begin Period Cash Flow in the same time period over historical financial statements of Arcadia Biosciences, assuming nothing else is changed. The correlation between historical values of Arcadia Biosciences' Cash Flows Other Operating and Begin Period Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cash Flows Other Operating of Arcadia Biosciences are associated (or correlated) with its Begin Period Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Begin Period Cash Flow has no effect on the direction of Cash Flows Other Operating i.e., Arcadia Biosciences' Cash Flows Other Operating and Begin Period Cash Flow go up and down completely randomly.

Correlation Coefficient

-0.44
Relationship DirectionNegative 
Relationship StrengthVery Weak

Cash Flows Other Operating

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.
Most indicators from Arcadia Biosciences' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Arcadia Biosciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Arcadia Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
For information on how to trade Arcadia Stock refer to our How to Trade Arcadia Stock guide.At present, Arcadia Biosciences' Tax Provision is projected to decrease significantly based on the last few years of reporting. The current year's Issuance Of Capital Stock is expected to grow to about 11.4 M, whereas Selling General Administrative is forecasted to decline to about 14.7 M.
 2021 2022 2023 2024 (projected)
Total Operating Expenses26.8M19.6M16.0M21.7M
Cost Of Revenue8.7M9.8M3.3M3.1M

Arcadia Biosciences fundamental ratios Correlations

0.56-0.29-0.150.880.29-0.180.03-0.280.510.510.720.110.93-0.190.030.50.210.520.420.430.260.97-0.140.040.49
0.560.010.170.18-0.190.560.70.520.020.020.560.130.59-0.02-0.510.9-0.41-0.23-0.380.9-0.30.49-0.250.370.94
-0.290.010.75-0.510.230.180.250.22-0.68-0.29-0.20.31-0.260.35-0.270.130.01-0.25-0.30.320.16-0.280.460.43-0.15
-0.150.170.75-0.340.170.10.070.16-0.280.10.050.6-0.180.37-0.160.050.04-0.17-0.20.310.12-0.20.080.56-0.08
0.880.18-0.51-0.340.4-0.47-0.36-0.570.640.670.570.080.81-0.180.270.080.450.760.73-0.010.420.87-0.27-0.130.13
0.29-0.190.230.170.4-0.38-0.37-0.360.010.370.390.470.150.370.1-0.150.860.770.45-0.10.960.220.00.44-0.35
-0.180.560.180.1-0.47-0.380.580.96-0.33-0.260.11-0.12-0.10.31-0.810.6-0.6-0.65-0.890.6-0.55-0.25-0.110.460.57
0.030.70.250.07-0.36-0.370.580.58-0.44-0.690.05-0.010.1-0.18-0.380.72-0.61-0.55-0.610.7-0.390.020.030.170.73
-0.280.520.220.16-0.57-0.360.960.58-0.33-0.290.06-0.1-0.180.29-0.830.59-0.59-0.69-0.930.61-0.53-0.35-0.030.50.54
0.510.02-0.68-0.280.640.01-0.33-0.44-0.330.590.37-0.140.48-0.480.13-0.040.060.340.44-0.110.020.49-0.1-0.26-0.02
0.510.02-0.290.10.670.37-0.26-0.69-0.290.590.50.180.440.280.05-0.10.50.580.47-0.070.30.46-0.280.17-0.08
0.720.56-0.20.050.570.390.110.050.060.370.50.410.510.2-0.10.460.230.290.080.450.350.52-0.260.430.46
0.110.130.310.60.080.47-0.12-0.01-0.1-0.140.180.41-0.070.420.21-0.110.360.250.090.050.54-0.01-0.410.7-0.07
0.930.59-0.26-0.180.810.15-0.10.1-0.180.480.440.51-0.07-0.32-0.140.580.060.420.40.50.080.96-0.08-0.050.54
-0.19-0.020.350.37-0.180.370.31-0.180.29-0.480.280.20.42-0.32-0.22-0.130.360.1-0.27-0.020.26-0.31-0.390.66-0.08
0.03-0.51-0.27-0.160.270.1-0.81-0.38-0.830.130.05-0.10.21-0.14-0.22-0.620.440.420.64-0.650.360.06-0.07-0.49-0.42
0.50.90.130.050.08-0.150.60.720.59-0.04-0.10.46-0.110.58-0.13-0.62-0.41-0.29-0.440.96-0.290.460.130.270.89
0.21-0.410.010.040.450.86-0.6-0.61-0.590.060.50.230.360.060.360.44-0.410.880.63-0.380.890.17-0.090.16-0.47
0.52-0.23-0.25-0.170.760.77-0.65-0.55-0.690.340.580.290.250.420.10.42-0.290.880.79-0.320.790.53-0.240.02-0.29
0.42-0.38-0.3-0.20.730.45-0.89-0.61-0.930.440.470.080.090.4-0.270.64-0.440.630.79-0.470.580.49-0.05-0.4-0.43
0.430.90.320.31-0.01-0.10.60.70.61-0.11-0.070.450.050.5-0.02-0.650.96-0.38-0.32-0.47-0.240.380.140.410.82
0.26-0.30.160.120.420.96-0.55-0.39-0.530.020.30.350.540.080.260.36-0.290.890.790.58-0.240.19-0.010.31-0.43
0.970.49-0.28-0.20.870.22-0.250.02-0.350.490.460.52-0.010.96-0.310.060.460.170.530.490.380.19-0.08-0.10.44
-0.14-0.250.460.08-0.270.0-0.110.03-0.03-0.1-0.28-0.26-0.41-0.08-0.39-0.070.13-0.09-0.24-0.050.14-0.01-0.08-0.31-0.23
0.040.370.430.56-0.130.440.460.170.5-0.260.170.430.7-0.050.66-0.490.270.160.02-0.40.410.31-0.1-0.310.17
0.490.94-0.15-0.080.13-0.350.570.730.54-0.02-0.080.46-0.070.54-0.08-0.420.89-0.47-0.29-0.430.82-0.430.44-0.230.17
Click cells to compare fundamentals

Arcadia Biosciences Account Relationship Matchups

Arcadia Biosciences fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets32.6M47.3M43.9M28.9M19.7M35.9M
Other Current Liab4.5M3.0M1.5M1.3M1.1M1.8M
Total Current Liabilities5.7M6.3M5.0M4.2M3.6M4.1M
Total Stockholder Equity7.7M27.7M31.1M21.0M12.8M14.6M
Property Plant And Equipment Net3.8M9.4M5.4M2.6M1.2M1.1M
Current Deferred Revenue42K8K64K(572K)(514.8K)(489.1K)
Net Debt(6.2M)(4.7M)(25.4M)(18.6M)(5.5M)(5.8M)
Retained Earnings(207.2M)(211.8M)(226.5M)(257.9M)(271.8M)(285.4M)
Accounts Payable492K726K1.4M905K801K970.9K
Cash8.4M14.0M28.7M20.6M6.5M6.2M
Non Current Assets Total4.1M15.7M8.5M3.5M4.7M5.5M
Non Currrent Assets Other372K5.5M2.7M932K3.5M2.5M
Cash And Short Term Investments25.3M25.7M28.7M20.6M11.6M11.1M
Net Receivables602K1.4M1.4M1.2M514K767.9K
Common Stock Shares Outstanding159.1K249.0K532.0K599.4K1.2M1.3M
Liabilities And Stockholders Equity32.6M47.3M43.9M28.9M19.7M35.9M
Non Current Liabilities Total18.5M12.5M7.7M3.8M3.4M3.2M
Inventory1.8M3.8M4.4M2.6M2.0M1.6M
Other Current Assets712K1.6M1.8M1.2M858K914.0K
Other Stockholder Equity214.8M239.5M257.5M278.8M284.5M207.1M
Total Liab24.2M18.8M12.7M8.0M7.0M6.7M
Property Plant And Equipment Gross3.8M9.4M5.4M2.6M3.7M2.7M
Total Current Assets28.4M31.7M35.4M25.4M15.0M28.3M
Accumulated Other Comprehensive Income(4.8M)1K0.0101K116.2K122.0K
Other Liab8.2M16.9M5.0M5.5M6.3M8.1M
Other Assets372K5.5M2.7M1.00.90.86
Short Term Debt635K2.6M2.1M2.0M1.7M1.6M
Property Plant Equipment1.1M2.2M9.4M5.4M6.2M3.1M
Net Tangible Assets12.8M7.7M26.9M30.6M35.2M37.0M
Common Stock Total Equity42K45K49K54K62.1K51.0K
Retained Earnings Total Equity(167.3M)(178.4M)(207.2M)(211.8M)(190.6M)(200.2M)
Short Term Investments9.8M16.9M11.6M0.05.1M4.9M
Capital Surpluse175.2M191.1M214.8M239.5M275.4M213.9M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Arcadia Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Arcadia Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Arcadia Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Arcadia Biosciences Stock:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Arcadia Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
For information on how to trade Arcadia Stock refer to our How to Trade Arcadia Stock guide.
You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Is Agricultural Products & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Arcadia Biosciences. If investors know Arcadia will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Arcadia Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.285
Earnings Share
(6.77)
Revenue Per Share
3.802
Quarterly Revenue Growth
(0.04)
Return On Assets
(0.39)
The market value of Arcadia Biosciences is measured differently than its book value, which is the value of Arcadia that is recorded on the company's balance sheet. Investors also form their own opinion of Arcadia Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Arcadia Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Arcadia Biosciences' market value can be influenced by many factors that don't directly affect Arcadia Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Arcadia Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Arcadia Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Arcadia Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.